Femtech 2.0 — From Tracking to Biomarkers
The "Femtech" sector has undergone its biggest transformation yet in 2026, moving from basic period-tracking apps to sophisticated clinical-grade platforms.
Measurable Metrics: 2026 apps focus on biomarkers (measurable biological markers) rather than just self-reported symptoms. Integration with Oura Rings and continuous glucose monitors (CGM) allows for real-time tracking of cycle-related metabolic changes.
Menstrual Blood Diagnostics: A revolutionary trend in 2026 is the use of diagnostic sanitary products that analyze menstrual blood for markers of endometriosis, HPV, and nutrient deficiencies.
AI Personalization: Advanced AI "health coaches" now predict hormonal shifts before they occur, providing personalized nutrition and exercise recommendations based on the specific day of a woman's cycle.
